This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joy Y. Weissman, MD; Mark M. Tsuchiyose, MD; Myron J. Tong, PhD, MD; Ruth Co, RN; Kenneth Chin, MD; Robert B. Ettenger, MD

JAMA. 1988;260(12):1734-1738.

Abstract
Yeast recombinant hepatitis B vaccine was administered to 25 nonresponders to the plasma-derived hepatitis B vaccine. After three 10-µg doses, nine subjects (36%) produced levels of antibodies to hepatitis B surface antigen (antiHBs) of less than 2.1 sample ratio units (SRU) (nonresponders), and five (20%) developed anti-HBs of 2.1 to 9.9 SRU (hyporesponders); anti-HBs levels of 10 SRU or greater were detected at least once in 11 vaccinees (44%), but by the sixth and 12th months after the last vaccination, only three and one of these "responders," respectively, still maintained anti-HBs values of 10 SRU or greater. In these 25 subjects HLA subtyping showed a high prevalence of DR7, B8, and the combinations of DR3 and DR7 and DR4 and DR7. Our findings indicate that the yeast recombinant hepatitis B vaccine was not effective in eliciting a sustained anti-HBs response in nonresponders to the plasma hepatitis B vaccine.

(JAMA 1988;260:1734-1738)

Author Affiliations
From the Liver Center, Huntington Memorial Hospital, Pasadena, Calif (Drs Weissman, Tsuchiyose, Tong, and Chin and Ms Co), and the Division of Pediatric Nephrology, University of California, Los Angeles Medical Center (Dr Ettenger).

Footnotes
Reprint requests to the Liver Center, Huntington Memorial Hospital, 100 Congress St, Pasadena, CA 91105 (Dr Tong).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Totally Synthetic Polyoxime Malaria Vaccine Containing Plasmodium falciparum B Cell and Universal T Cell Epitopes Elicits Immune Responses in Volunteers of Diverse HLA Types
Nardin et al.
J. Immunol. 2001;166:481-489.
ABSTRACT | FULL TEXT  

Reversal of Nonresponders and Postexposure Prophylaxis by Intradermal Hepatitis B Vaccination in Japanese Medical Personnel
Nagafuchi et al.
JAMA 1991;265:2679-2683.
ABSTRACT  

Predicting Patient Outcome from Intensive Care: A Guide to APACHE, MPM, SAPS, PRISM, and Other Prognostic Scoring Systems
Seneff and Knaus
J Intensive Care Med 1990;5:33-52.
ABSTRACT  

HLA and Immune Response
McCombs and Michalski
JAMA 1989;262:774-774.
ABSTRACT